Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6812
Rank
ยฃ0.45 B
Marketcap
ยฃ22.93
Share price
-1.03%
Change (1 day)
-7.96%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ3.87 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company has ยฃ3.87 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avalon Pharma (Middle East Pharmaceutical) - Cash on Hand chart (from 2023 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ4.8 M51.92%
2023-12-31ยฃ3.16 M